EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic

Ting-Ting Jiang, Lin Sun, Tian-Yi Wang, Hui Qi, He Tang, Ya-Cui Wang, Qian Han, Xiao-Qing Shi, Jing Bi, Wei-Wei Jiao, A-Dong Shen

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1181402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Ting-Ting Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Baoding Key Laboratory for Precision Diagnosis and Treatment of Infectious Diseases in Children, Baoding Hospital of Beijing Children's Hospital, Cap…. Hauptthemen laut MEDLINE: Pneumonia, Mycoplasma, COVID-19, Community-Acquired Infections. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mycoplasma pneumoniae (MP) is a commonly occurring pathogen causing community-acquired pneumonia (CAP) in children. The global prevalence of macrolide-resistant MP (MRMP) infection, especially in Asian regions, is increasing rapidly. However, the prevalence of MRMP and its clinical significance during the COVID-19 pandemic is not clear.

Methods

This study enrolled children with molecularly confirmed macrolide-susceptible MP (MSMP) and MRMP CAP from Beijing Children’s Hospital Baoding Hospital, Capital Medical University between August 2021 and July 2022. The clinical characteristics, laboratory findings, chest imaging presentations, and strain genotypes were compared between patients with MSMP and MRMP CAP.

Results

A total of 520 hospitalized children with MP-CAP were enrolled in the study, with a macrolide resistance rate of 92.7%. Patients with MRMP infection exhibited more severe clinical manifestations (such as dyspnea and pleural effusion) and had a longer hospital stay than the MSMP group. Furthermore, abnormal blood test results (including increased LDH and D-dimer) were more common in the MRMP group (P<0.05). Multilocus variable-number tandem-repeat analysis (MLVA) was performed on 304 samples based on four loci (Mpn13-16), and M3562 and M4572 were the major types, accounting for 74.0% and 16.8% of the strains, respectively. The macrolide resistance rate of M3562 strains was up to 95.1%.

Conclusion

The prevalence of MRMP strains in hospitalized CAP patients was extremely high in the Baoding area, and patients infected with MRMP strains exhibited more severe clinical features and increased LDH and D-dimer. M3562 was the predominant resistant clone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, MycoplasmaCOVID-19Community-Acquired InfectionsChildHumansAnti-Bacterial AgentsMacrolidesClinical RelevancePandemicsDrug Resistance, BacterialMycoplasma pneumoniae

Stichwörter der Autor:innen

Mycoplasma pneumoniaechildrenclinical featuredrug resistancegenotyping

Substanzen

Anti-Bacterial AgentsMacrolides

Autor:innen und Institutionen

  • Baoding Key Laboratory for Precision Diagnosis and Treatment of Infectious Diseases in Children, Baoding Hospital of Beijing Children's Hospital, Capital Medical University, Baoding, Hebei, China.
  • Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), National Clinical Research Center for Respiratory Diseases, Beijing Key Laboratory…

Zitieren

APA

Jiang, T. T., Sun, L., Wang, T. Y., Qi, H., Tang, H., Wang, Y. C., Han, Q., Shi, X. Q., Bi, J., Jiao, W. W., & Shen, A. D. (2023). The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1181402

Vancouver

Jiang TT, Sun L, Wang TY, Qi H, Tang H, Wang YC, et al. The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1181402

BibTeX
@article{Jiang2023,
  author = {Jiang, Ting-Ting and Sun, Lin and Wang, Tian-Yi and Qi, Hui and Tang, He and Wang, Ya-Cui and Han, Qian and Shi, Xiao-Qing and Bi, Jing and Jiao, Wei-Wei and Shen, A-Dong},
  title = {The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1181402}
}
Kostenlos starten →